PTC Therapeutics, Inc. (PTCT): Price and Financial Metrics
PTC Therapeutics, Inc. (PTCT)
Today's Latest Price: $42.56 USD
2.40 (-5.34%)
Updated Apr 3 4:00pm
Add PTCT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
PTCT Stock Summary
- PTCT's price/sales ratio is 8.68; that's higher than the P/S ratio of 90.49% of US stocks.
- With a year-over-year growth in debt of 105.12%, Ptc Therapeutics Inc's debt growth rate surpasses 86.48% of about US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Ptc Therapeutics Inc is reporting a growth rate of 96.82%; that's higher than 88.79% of US stocks.
- Stocks that are quantitatively similar to PTCT, based on their financial statements, market capitalization, and price volatility, are RTRX, RMBS, KPTI, SRPT, and XPL.
- Visit PTCT's SEC page to see the company's official filings. To visit the company's web site, go to www.ptcbio.com.
PTCT Daily Price Range
PTCT 52-Week Price Range
PTCT Stock Price Chart More Charts
PTCT Price/Volume Stats
| Current price | $42.56 | 52-week high | $59.89 |
| Prev. close | $44.96 | 52-week low | $30.79 |
| Day low | $42.25 | Volume | 631,800 |
| Day high | $45.76 | Avg. volume | 981,608 |
| 50-day MA | $49.69 | Dividend yield | N/A |
| 200-day MA | $45.30 | Market Cap | 2.67B |
PTC Therapeutics, Inc. (PTCT) Company Bio
PTC Therapeutics is a global biopharmaceutical company focused on the discovery, development and commercialization of orally administered, proprietary small molecule drugs targeting an area of RNA biology we refer to as post-transcriptional control. The company was founded in 1998 and is based in South Plainfield, New Jersey.
Loading social stream, please wait...